LeonaBio (LONA) Total Current Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 21.38% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 21.38% increase from a year earlier, with the FY2025 full-year figure at $47.5 million, up 261.65% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $6.7 million, down from $47.5 million in the prior quarter.
• Over the last five years, Total Current Liabilities for LONA reached as high as $47.5 million in Q4 2025 and fell as low as $2.8 million in Q3 2025.
• Historically, Total Current Liabilities has averaged $18.2 million across 5 years, with a median of $20.2 million in 2023.
• On a YoY basis, Total Current Liabilities climbed as much as 261.65% in 2025 and fell as far as 89.96% in 2025.
• Year by year, Total Current Liabilities stood at $21.4 million in 2022, then soared by 34.57% to $28.8 million in 2023, then sank by 54.46% to $13.1 million in 2024, then soared by 261.65% to $47.5 million in 2025, then tumbled by 85.97% to $6.7 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $6.7 million in Q1 2026, $47.5 million in Q4 2025, and $2.8 million in Q3 2025.